Article
Compound heterozygosity in nonphenylketonuria hyperphenylalanemia: the contribution of mutations for classical phenylketonuria.
American journal of human genetics - 1 Aug 1991
Avigad S, Kleiman S, Weinstein M, Cohen B E, Schwartz G, Woo S L, Shiloh Y
Abstract excerpt
Hyperphenylalaninemia (HPA) results from defective hydroxylation of phenylalanine in the liver, in most cases because of defective phenylalanine hydroxylase. HPA is highly variable, ranging from moderate elevation of plasma phenylalanine with no clinical consequences to a severe disease, classical phenylketonuria (PKU). Non-PKU HPA was found in excess of PKU in Israel, while the opposite is true in Europe. To...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
